Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nylis versus dimethicone versus permethrin for head lice in elementary school girls
IRCT20190908044720N1Phase 3Completed
- Sponsor
- Bushehr University of Medical Sciences
- Start
- Nov 2019
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of dimeticone and permethrin in pediculosis capitis (3 arms), sponsored by Bushehr University of Medical Sciences. Primary endpoint: Cure rate. Started Nov 2019; status: completed.
02
Drugs
dimeticonepermethrin
03
Conditions
pediculosis capitis
Beyond the preview
Go deeper on IRCT20190908044720N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190908044720N1.